Europe Bispecific Antibody Market Research Report Forecast 2017-2021

June 2017 | 101 pages | ID: ECBC52328FFEN
S&P Consulting

Abstracts

The Europe Bispecific Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Bispecific Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Bispecific Antibody market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Europe Bispecific Antibody Market Analysis by Countries:

Germany
France
UK
Russia
Italy
Spain
Benelux

The Major players reported in the market include:

Bayer
Eli Lilly
Sanofi
Roche
Pfizer
Merus
NovImmune SA
Jounce Therapeutics
Amgen

Europe Bispecific Antibody Market Analysis by Product :

• Type 1
• Type 2
• Type 3

Europe Bispecific Antibody Market Analysis by Application:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

1 BISPECIFIC ANTIBODY MARKET OVERVIEW

1.1 Product Overview and Scope of Bispecific Antibody
1.2 Classification of Bispecific Antibody
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Bispecific Antibody
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Bispecific Antibody Market States Status and Prospect (2012-2021) by Countries
  1.4.1 Germany
  1.4.2 France
  1.4.3 UK
  1.4.4 Russia
  1.4.5 Italy
  1.4.6 Spain
  1.4.7 Benelux
1.5 Europe Market Size (Value and Volume) of Bispecific Antibody (2012-2021)
  1.5.1 Europe Bispecific Antibody Sales and Growth Rate (2012-2021)
  1.5.2 Europe Bispecific Antibody Revenue and Growth Rate (2012-2021)

2 EUROPE ECONOMIC IMPACT ON BISPECIFIC ANTIBODY INDUSTRY

2.1 Europe Macroeconomic Analysis
2.2 Europe Macroeconomic Environment Development Trend

3 BISPECIFIC ANTIBODY MANUFACTURING COST ANALYSIS

3.1 Bispecific Antibody Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Bispecific Antibody

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Bispecific Antibody Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Bispecific Antibody Major Manufacturers in 2015
4.4 Downstream Buyers

5 EUROPE BISPECIFIC ANTIBODY MARKET ANALYSIS BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Europe Bispecific Antibody Market Competition by Manufacturers
  5.1.1 Europe Bispecific Antibody Sales and Market Share of Key Manufacturers (2015 and 2016)
  5.1.2 Europe Bispecific Antibody Revenue and Share by Manufacturers (2015 and 2016)
5.2 Europe Bispecific Antibody (Volume and Value) by Type
  5.2.1 Europe Bispecific Antibody Sales and Market Share by Type (2012-2017)
  5.2.2 Europe Bispecific Antibody Revenue and Market Share by Type (2012-2017)
5.3 Europe Bispecific Antibody (Volume and Value) by Countries
  5.3.1 Europe Bispecific Antibody Sales and Market Share by Countries (2012-2017)
  5.3.2 Europe Bispecific Antibody Revenue and Market Share by Countries (2012-2017)
5.4 Europe Bispecific Antibody (Volume) by Application

6 GERMANY BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

6.1 Germany Bispecific Antibody Sales and Value (2012-2017)
  6.1.1 Germany Bispecific Antibody Sales and Growth Rate (2012-2017)
  6.1.2 Germany Bispecific Antibody Revenue and Growth Rate (2012-2017)
  6.1.3 Germany Bispecific Antibody Sales Price Trend (2012-2017)
6.2 Germany Bispecific Antibody Sales and Market Share by Manufacturers
6.3 Germany Bispecific Antibody Sales and Market Share by Type
6.4 Germany Bispecific Antibody Sales and Market Share by Application

7 FRANCE BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

7.1 France Bispecific Antibody Sales and Value (2012-2017)
  7.1.1 France Bispecific Antibody Sales and Growth Rate (2012-2017)
  7.1.2 France Bispecific Antibody Revenue and Growth Rate (2012-2017)
  7.1.3 France Bispecific Antibody Sales Price Trend (2012-2017)
7.2 France Bispecific Antibody Sales and Market Share by Manufacturers
7.3 France Bispecific Antibody Sales and Market Share by Type
7.4 France Bispecific Antibody Sales and Market Share by Application

8 UK BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

8.1 UK Bispecific Antibody Sales and Value (2012-2017)
  8.1.1 UK Bispecific Antibody Sales and Growth Rate (2012-2017)
  8.1.2 UK Bispecific Antibody Revenue and Growth Rate (2012-2017)
  8.1.3 UK Bispecific Antibody Sales Price Trend (2012-2017)
8.2 UK Bispecific Antibody Sales and Market Share by Manufacturers
8.3 UK Bispecific Antibody Sales and Market Share by Type
8.4 UK Bispecific Antibody Sales and Market Share by Application

9 RUSSIA BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

9.1 Russia Bispecific Antibody Sales and Value (2012-2017)
  9.1.1 Russia Bispecific Antibody Sales and Growth Rate (2012-2017)
  9.1.2 Russia Bispecific Antibody Revenue and Growth Rate (2012-2017)
  9.1.3 Russia Bispecific Antibody Sales Price Trend (2012-2017)
9.2 Russia Bispecific Antibody Sales and Market Share by Manufacturers
9.3 Russia Bispecific Antibody Sales and Market Share by Type
9.4 Russia Bispecific Antibody Sales and Market Share by Application

10 ITALY BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

10.1 Italy Bispecific Antibody Sales and Value (2012-2017)
  10.1.1 Italy Bispecific Antibody Sales and Growth Rate (2012-2017)
  10.1.2 Italy Bispecific Antibody Revenue and Growth Rate (2012-2017)
  10.1.3 Italy Bispecific Antibody Sales Price Trend (2012-2017)
10.2 Italy Bispecific Antibody Sales and Market Share by Manufacturers
10.3 Italy Bispecific Antibody Sales and Market Share by Type
10.4 Italy Bispecific Antibody Sales and Market Share by Application

11 SPAIN BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

11.1 Spain Bispecific Antibody Sales and Value (2012-2017)
  11.1.1 Spain Bispecific Antibody Sales and Growth Rate (2012-2017)
  11.1.2 Spain Bispecific Antibody Revenue and Growth Rate (2012-2017)
  11.1.3 Spain Bispecific Antibody Sales Price Trend (2012-2017)
11.2 Spain Bispecific Antibody Sales and Market Share by Manufacturers
11.3 Spain Bispecific Antibody Sales and Market Share by Type
11.4 Spain Bispecific Antibody Sales and Market Share by Application

12 BENELUX BISPECIFIC ANTIBODY (VOLUME, VALUE AND SALES PRICE)

12.1 Benelux Bispecific Antibody Sales and Value (2012-2017)
  12.1.1 Benelux Bispecific Antibody Sales and Growth Rate (2012-2017)
  12.1.2 Benelux Bispecific Antibody Revenue and Growth Rate (2012-2017)
  12.1.3 Benelux Bispecific Antibody Sales Price Trend (2012-2017)
12.2 Benelux Bispecific Antibody Sales and Market Share by Manufacturers
12.3 Benelux Bispecific Antibody Sales and Market Share by Type
12.4 Benelux Bispecific Antibody Sales and Market Share by Application

13 EUROPE BISPECIFIC ANTIBODY MANUFACTURERS ANALYSIS

13.1 Bayer
  13.1.1 Company Basic Information, Manufacturing Base and Competitors
  13.1.2 Product Type, Application and Specification
  13.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.1.4 Business Overview
13.2 Eli Lilly
  13.2.1 Company Basic Information, Manufacturing Base and Competitors
  13.2.2 Product Type, Application and Specification
  13.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.2.4 Business Overview
13.3 Sanofi
  13.3.1 Company Basic Information, Manufacturing Base and Competitors
  13.3.2 Product Type, Application and Specification
  13.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.3.4 Business Overview
13.4 Roche
  13.4.1 Company Basic Information, Manufacturing Base and Competitors
  13.4.2 Product Type, Application and Specification
  13.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.4.4 Business Overview
13.5 Pfizer
  13.5.1 Company Basic Information, Manufacturing Base and Competitors
  13.5.2 Product Type, Application and Specification
  13.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.5.4 Business Overview
13.6 Merus
  13.6.1 Company Basic Information, Manufacturing Base and Competitors
  13.6.2 Product Type, Application and Specification
  13.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.6.4 Business Overview
13.7 NovImmune SA
  13.7.1 Company Basic Information, Manufacturing Base and Competitors
  13.7.2 Product Type, Application and Specification
  13.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.7.4 Business Overview
13.8 Jounce Therapeutics
  13.8.1 Company Basic Information, Manufacturing Base and Competitors
  13.8.2 Product Type, Application and Specification
  13.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.8.4 Business Overview
13.9 Amgen
  13.9.1 Company Basic Information, Manufacturing Base and Competitors
  13.9.2 Product Type, Application and Specification
  13.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  13.9.4 Business Overview

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 EUROPE BISPECIFIC ANTIBODY MARKET FORECAST (2017-2021)

15.1 Germany Market Forecast (2017-2021)
15.2 France Market Forecast (2017-2021)
15.3 UK Market Forecast (2017-2021)
15.4 Russia Market Forecast (2017-2021)
15.5 Italy Market Forecast (2017-2021)
15.6 Spain Market Forecast (2017-2021)
15.7 Benelux Market Forecast (2017-2021)
15.8 Europe Bispecific Antibody Market Forecast by Type (2017-2021)
15.9 Europe Bispecific Antibody Market Forecast by Application (2017-2021)

16 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bispecific Antibody
Table Classification of Bispecific Antibody
Figure Europe Sales Market Share of Bispecific Antibody by Type in 2015
Table Application of Bispecific Antibody
Figure Europe Sales Market Share of Bispecific Antibody by Application in 2015
Figure Germany Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure France Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure UK Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure Russia Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure Italy Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure Spain Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure Benelux Bispecific Antibody Revenue and Growth Rate (2012-2021)
Figure Europe Bispecific Antibody Sales and Growth Rate (2012-2021)
Figure Europe Bispecific Antibody Revenue and Growth Rate (2012-2021)
Table Europe Bispecific Antibody Sales of Key Manufacturers (2015 and 2016)
Table Europe Bispecific Antibody Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Bispecific Antibody Sales Share by Manufacturers
Figure 2016 Bispecific Antibody Sales Share by Manufacturers
Table Europe Bispecific Antibody Revenue by Manufacturers (2015 and 2016)
Table Europe Bispecific Antibody Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Bispecific Antibody Revenue Share by Manufacturers
Table 2016 Europe Bispecific Antibody Revenue Share by Manufacturers
Table Europe Bispecific Antibody Sales and Market Share by Type (2012-2017)
Table Europe Bispecific Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Bispecific Antibody by Type (2012-2017)
Figure Europe Bispecific Antibody Sales Growth Rate by Type (2012-2017)
Table Europe Bispecific Antibody Revenue and Market Share by Type (2012-2017)
Table Europe Bispecific Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Bispecific Antibody by Type (2012-2017)
Figure Europe Bispecific Antibody Revenue Growth Rate by Type (2012-2017)
Table Europe Bispecific Antibody Sales and Market Share by Countries (2012-2017)
Table Europe Bispecific Antibody Sales Share by Countries (2012-2017)
Figure Sales Market Share of Bispecific Antibody by Countries (2012-2017)
Table Europe Bispecific Antibody Revenue and Market Share by Countries (2012-2017)
Table Europe Bispecific Antibody Revenue Share by Countries (2012-2017)
Figure Revenue Market Share of Bispecific Antibody by Countries (2012-2017)
Table Europe Bispecific Antibody Sales and Market Share by Application (2012-2017)
Table Europe Bispecific Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Bispecific Antibody by Application (2012-2017)
Figure Germany Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure Germany Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure Germany Bispecific Antibody Sales Price Trend (2012-2017)
Table Germany Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table Germany Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table Germany Bispecific Antibody Sales by Type (2015 and 2016)
Table Germany Bispecific Antibody Market Share by Type (2015 and 2016)
Table Germany Bispecific Antibody Sales by Application (2015 and 2016)
Table Germany Bispecific Antibody Market Share by Application (2015 and 2016)
Figure France Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure France Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure France Bispecific Antibody Sales Price Trend (2012-2017)
Table France Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table France Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table France Bispecific Antibody Sales by Type (2015 and 2016)
Table France Bispecific Antibody Market Share by Type (2015 and 2016)
Table France Bispecific Antibody Sales by Application (2015 and 2016)
Table France Bispecific Antibody Market Share by Application (2015 and 2016)
Figure UK Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure UK Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure UK Bispecific Antibody Sales Price Trend (2012-2017)
Table UK Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table UK Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table UK Bispecific Antibody Sales by Type (2015 and 2016)
Table UK Bispecific Antibody Market Share by Type (2015 and 2016)
Table UK Bispecific Antibody Sales by Application (2015 and 2016)
Table UK Bispecific Antibody Market Share by Application (2015 and 2016)
Figure Russia Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure Russia Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure Russia Bispecific Antibody Sales Price Trend (2012-2017)
Table Russia Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table Russia Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table Russia Bispecific Antibody Sales by Type (2015 and 2016)
Table Russia Bispecific Antibody Market Share by Type (2015 and 2016)
Table Russia Bispecific Antibody Sales by Application (2015 and 2016)
Table Russia Bispecific Antibody Market Share by Application (2015 and 2016)
Figure Italy Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure Italy Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure Italy Bispecific Antibody Sales Price Trend (2012-2017)
Table Italy Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table Italy Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table Italy Bispecific Antibody Sales by Type (2015 and 2016)
Table Italy Bispecific Antibody Market Share by Type (2015 and 2016)
Table Italy Bispecific Antibody Sales by Application (2015 and 2016)
Table Italy Bispecific Antibody Market Share by Application (2015 and 2016)
Figure Spain Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure Spain Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure Spain Bispecific Antibody Sales Price Trend (2012-2017)
Table Spain Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table Spain Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table Spain Bispecific Antibody Sales by Type (2015 and 2016)
Table Spain Bispecific Antibody Market Share by Type (2015 and 2016)
Table Spain Bispecific Antibody Sales by Application (2015 and 2016)
Table Spain Bispecific Antibody Market Share by Application (2015 and 2016)
Figure Benelux Bispecific Antibody Sales and Growth Rate (2012-2017)
Figure Benelux Bispecific Antibody Revenue and Growth Rate (2012-2017)
Figure Benelux Bispecific Antibody Sales Price Trend (2012-2017)
Table Benelux Bispecific Antibody Sales by Manufacturers (2015 and 2016)
Table Benelux Bispecific Antibody Market Share by Manufacturers (2015 and 2016)
Table Benelux Bispecific Antibody Sales by Type (2015 and 2016)
Table Benelux Bispecific Antibody Market Share by Type (2015 and 2016)
Table Benelux Bispecific Antibody Sales by Application (2015 and 2016)
Table Benelux Bispecific Antibody Market Share by Application (2015 and 2016)
Table Bayer Basic Information List
Table Bayer Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Bispecific Antibody Sales Market Share (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Eli Lilly Bispecific Antibody Sales Market Share (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Sanofi Bispecific Antibody Sales Market Share (2012-2017)
Table Roche Basic Information List
Table Roche Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Roche Bispecific Antibody Sales Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Bispecific Antibody Sales Market Share (2012-2017)
Table Merus Basic Information List
Table Merus Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merus Bispecific Antibody Sales Market Share (2012-2017)
Table NovImmune SA Basic Information List
Table NovImmune SA Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure NovImmune SA Bispecific Antibody Sales Market Share (2012-2017)
Table Jounce Therapeutics Basic Information List
Table Jounce Therapeutics Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Table Jounce Therapeutics Bispecific Antibody Sales Market Share (2012-2017)
Table Amgen Basic Information List
Table Amgen Bispecific Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Amgen Bispecific Antibody Sales Market Share (2012-2017).
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bispecific Antibody
Figure Manufacturing Process Analysis of Bispecific Antibody
Figure Bispecific Antibody Industrial Chain Analysis
Table Raw Materials Sources of Bispecific Antibody Major Manufacturers in 2015
Table Major Buyers of Bispecific Antibody
Table Distributors/Traders List
Figure Germany Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Germany Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure France Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure France Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure UK Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure UK Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Russia Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Russia Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Italy Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Italy Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Spain Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Spain Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Figure Benelux Bispecific Antibody Sales and Growth Rate Forecast (2017-2021)
Figure Benelux Bispecific Antibody Revenue and Growth Rate Forecast (2017-2021)
Table Europe Bispecific Antibody Sales Forecast by Type (2017-2021)
Table Europe Bispecific Antibody Sales Forecast by Application (2017-2021)